For investors seeking to bolster their portfolios with reliable income and compelling growth prospects, a closer look at a trio of dividend powerhouses reveals strong reasons to consider increasing your stake. These companies, each a leader in its respective sector, combine consistent shareholder returns with solid fundamentals and clear runways for future expansion.
First on the list is AbbVie (NYSE: ABBV), a true “Dividend King” with an impressive streak of 53 consecutive years of dividend increases. Sporting a forward dividend yield currently exceeding 3.5%, AbbVie offers an attractive income stream. While the recent loss of exclusivity for its blockbuster drug Humira has presented challenges, the company is poised for accelerated growth in the coming years. Sales of its successful immunology successors, Rinvoq and Skyrizi, are soaring, and AbbVie’s robust pipeline of new therapies is expected to drive significant revenue expansion, offsetting the Humira impact.
Next, consider Enterprise Products Partners (NYSE: EPD), a master limited partnership (MLP) known for its exceptionally high distributions. With an ultra-high forward distribution yield of nearly 7% and a remarkable track record of 26 consecutive years of distribution increases, Enterprise provides substantial cash flow to investors. Beyond its generous payouts, the company is strategically positioned to benefit from two major trends: the explosion in U.S. data centers, many of which will rely on natural gas for power, and the surging global demand for U.S. oil, natural gas, and natural gas liquids, all of which flow through Enterprise’s extensive pipeline network. Even without significant stock appreciation, its high distribution promises attractive total returns.
Finally, for real estate exposure, Realty Income (NYSE: O) stands out as a premier real estate investment trust (REIT). Affectionately known as “The Monthly Dividend Company,” it boasts a forward dividend yield of 5.66% and, true to its nickname, distributes its dividend monthly. Realty Income has increased its dividend for an impressive 30 consecutive years, with a total of 131 dividend hikes since its 1994 IPO. The company has also delivered a positive total operational return every single year since its public debut, averaging roughly 11%. Its growth prospects are strong, with a vast $14 trillion total addressable market, particularly in Europe where it faces limited competition from major rivals.
AbbVie, Enterprise Products Partners, and Realty Income offer compelling reasons for dividend investors to consider “doubling up.” AbbVie provides growth acceleration and a long dividend history, Enterprise Products Partners delivers an ultra-high yield from essential energy infrastructure, and Realty Income offers consistent monthly dividends and strong real estate growth potential. Each stock combines attractive income with a clear path for future expansion.
Next: Buy Alert just triggered
My absolute favorite stock just hit a critical “buy now” trigger price.
This opportunity is killer.
The smart money is already buying up shares in this company keeping the AI boom alive.
Billionaire David Tepper 24 million shares…
Billionaire Seth Klarman bought 12 million shares…
Blackstone, Goldman Sachs, and Morgan Stanley are all major investors.
Tech will not survive without this company. As a 30 year Wall Street Veteran, I’m telling you — this is the future.
I’ve been waiting months for this stock to enter my buy zone and it just triggered.
This could be the easiest (and safest) money you ever make.
P.S. We’ve taken 13 profits this year and expect this “buy alert” to move quickly. So act fast before it’s too late >>>
